JM

Jashubhai Makwana Dulabhai

Active Director Director DIN 07769430
DIN 07769430 First appointment Aug 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Jashubhai Makwana Dulabhai

Data last updated:

Jashubhai Makwana Dulabhai is a Director at Maxxlife Bio Science Private Limited (since 2022). The company operates in Pharma.

DIN 07769430
Primary Designation Director
Industry Pharma
First Appointment 02 Aug 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Maxxlife Bio Science Private Limited U24290GJ2022PTC134434
Director02 Aug 20222022Active

Board colleagues of Jashubhai Makwana Dulabhai

Directorship timeline

Open interactive timeline →
Maxxlife Bio Science Private Limited
Premium access

Shareholding and investment profile for Jashubhai Makwana Dulabhai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jashubhai Makwana Dulabhai

Jashubhai Makwana Dulabhai currently holds 1 directorship: Maxxlife Bio Science Private Limited (Director, since 02 Aug 2022).

Jashubhai Makwana Dulabhai was first appointed on 02 Aug 2022 as Director at Maxxlife Bio Science Private Limited.

The current boards of Jashubhai Makwana Dulabhai's companies include Keshav Ramjibhai Katariya (Maxxlife Bio Science Private Limited), Manubhai Shyora Kathadbhai (Maxxlife Bio Science Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available